These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17260494)

  • 1. Gene expression of E-selectin in tissue and its protein level in serum of breast cancer patients.
    Shaker OG; Ay El-Deen MA; Abd El-Rahim MT; Talaat RM
    Tumori; 2006; 92(6):524-30. PubMed ID: 17260494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of soluble endothelial molecule E-selectin in patients with breast cancer.
    Hebbar M; Peyrat JP
    Int J Biol Markers; 2000; 15(1):15-21. PubMed ID: 10763135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on serum levels of E- selectin, integrin beta 1 subunit and intercellular adhesion molecule-1 in gastric cancer patients and their clinical implications].
    Shao QS; Ye ZY; Ling ZQ; Zhang W; Chen XR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):155-8. PubMed ID: 16155830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble E-selectin in women with breast cancer.
    Sheen-Chen SM; Eng HL; Huang CC; Chen WJ
    Br J Surg; 2004 Dec; 91(12):1578-81. PubMed ID: 15386328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble E-selectin are associated with the clinical course of metastatic disease in patients with liver metastases from breast cancer.
    Eichbaum MH; de Rossi TM; Kaul S; Bastert G
    Oncol Res; 2004; 14(11-12):603-10. PubMed ID: 15667001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotelial activation and flow-mediated vasodilation in young patients with breast cancer.
    Tesarova P; Kalousova M; Zima T; Suchanek M; Malikova I; Kvasnicka J; Duskova D; Tesar V; Vachek J; Krupickova-Kasalova Z; Malik J
    Neoplasma; 2013; 60(6):690-7. PubMed ID: 23906304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients.
    Hebbar M; Révillion F; Louchez MM; Fournier C; Bonneterre J; Peyrat JP
    Clin Cancer Res; 1999 Jun; 5(6):1427-33. PubMed ID: 10389928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased concentration of soluble E-selectin in the sera of breast cancer patients.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Anticancer Res; 1997; 17(2B):1367-72. PubMed ID: 9137500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
    Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
    Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
    Quaranta M; Daniele A; Coviello M; Savonarola A; Abbate I; Venneri MT; Paradiso A; Stea B; Zito A; Labriola A; Schittulli F
    Tumori; 2006; 92(4):311-7. PubMed ID: 17036522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
    Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
    Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.
    Hebbar M; Révillion F; Louchez MM; Vilain MO; Fournier C; Bonneterre J; Peyrat JP
    Clin Cancer Res; 1998 Feb; 4(2):373-80. PubMed ID: 9516925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients.
    Hebbar M; Krzewinski-Recchi MA; Hornez L; Verdière A; Harduin-Lepers A; Bonneterre J; Delannoy P; Peyrat JP
    Int J Biol Markers; 2003; 18(2):116-22. PubMed ID: 12841680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis.
    Byrne GJ; Ghellal A; Iddon J; Blann AD; Venizelos V; Kumar S; Howell A; Bundred NJ
    J Natl Cancer Inst; 2000 Aug; 92(16):1329-36. PubMed ID: 10944555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis.
    Decock J; Hendrickx W; Vanleeuw U; Van Belle V; Van Huffel S; Christiaens MR; Ye S; Paridaens R
    BMC Cancer; 2008 Mar; 8():77. PubMed ID: 18366705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
    Wu JD; Hong CQ; Huang WH; Wei XL; Zhang F; Zhuang YX; Zhang YQ; Zhang GJ
    Clin Breast Cancer; 2018 Oct; 18(5):e851-e861. PubMed ID: 29510897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma.
    O'Hanlon DM; Fitzsimons H; Lynch J; Tormey S; Malone C; Given HF
    Eur J Cancer; 2002 Nov; 38(17):2252-7. PubMed ID: 12441261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression and serum levels of HER-2/neu in patients with breast cancer.
    Krainer M; Brodowicz T; Zeillinger R; Wiltschke C; Scholten C; Seifert M; Kubista E; Zielinski CC
    Oncology; 1997; 54(6):475-81. PubMed ID: 9394844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.